2016
DOI: 10.1016/j.ajog.2016.04.024
|View full text |Cite
|
Sign up to set email alerts
|

North American Fetal Therapy Network: intervention vs expectant management for stage I twin-twin transfusion syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
44
0
4

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 56 publications
(48 citation statements)
references
References 12 publications
0
44
0
4
Order By: Relevance
“…Os principais desafios para o tratamento da STFF na atualidade incluem dúvidas quanto ao benefício da fotocoagulação das anastomoses no estágio I de Quintero 23 , uma vez que há a possibilidade de estabilização ou resolução espontânea do quadro, e a redução nos riscos de parto prematuro e sequelas neurológicas dos fetos que sobrevivem após a cirurgia.…”
Section: Principais Procedimentos Cirúrgicos Fetais I) Fotocoagulaçãounclassified
“…Os principais desafios para o tratamento da STFF na atualidade incluem dúvidas quanto ao benefício da fotocoagulação das anastomoses no estágio I de Quintero 23 , uma vez que há a possibilidade de estabilização ou resolução espontânea do quadro, e a redução nos riscos de parto prematuro e sequelas neurológicas dos fetos que sobrevivem após a cirurgia.…”
Section: Principais Procedimentos Cirúrgicos Fetais I) Fotocoagulaçãounclassified
“…Two studies published in 2016 complicated the field even further: An Australian report on 43 cases of stage 1 TTTS shows that the disease can remain stable or regress in up to 59% of cases, suggesting that conservative management would be an acceptable option. On the other hand, the North Atlantic Fetal Therapy Network (Naftnet) showed in a retrospective cohort of 124 cases that 60% progress and that fetoscopic laser ablation of the placental vascular anastomoses has the potential to reduce adverse outcomes. Both studies nevertheless agreed on the fact that stage 1 TTTS still has a high risk of fetal or neonatal mortality (20–23%) and therefore support the currently ongoing TTTS stage 1 trial, which is randomizing patients between expectant management and laser and should be nearing completion soon (http://www.clinicaltrials.gov – NCT01220011).…”
Section: Advances In Invasive Fetal Therapymentioning
confidence: 99%
“…Twin‐twin transfusion syndrome (TTTS) is a condition that affects monochorionic multiple gestations when placental vascular anastomoses cause the transfer of blood from one twin (donor) to the other (recipient) . Untreated TTTS is associated with substantial risk for perinatal death, preterm birth, and neurological impairment among survivors . The risk of such poor outcomes has led to development of various treatment modalities, including amnioreduction, selective feticide, and selective laser photocoagulation of the communicating vessels (SLPCV).…”
Section: Introductionmentioning
confidence: 99%